24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publication dates

All regions

Therapeutics Industry, February 2015 Market Reports from Top Publishers

You might be interested in: drug, medical equipment, cancer, melanoma, plc, multiple sclerosis, cancer drug, protein, breast cancer, colorectal cancer, drug delivery, antibody, leukemia, lymphoma, prostate cancer.


 
1-10 of about 1 600 reports for Therapeutics

Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market 2015  - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment

Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market 2015 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment

  • $ 3 500
  • Industry report
  • February 2015
  • by Kelly Scientific Publications

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by over 270 tables ...

Silence Therapeutics Plc

Silence Therapeutics Plc

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Silence Therapeutics Plc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

Imarx Therapeutics, Incorporation.

Imarx Therapeutics, Incorporation.

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Imarx Therapeutics, Incorporation. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

Sorrento Therapeutics Incorporation

Sorrento Therapeutics Incorporation

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Sorrento Therapeutics Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

United Therapeutics Corporation, Wright Investors' Service

United Therapeutics Corporation, Wright Investors' Service

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for United Therapeutics Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

Orexigen Therapeutics Inc

Orexigen Therapeutics Inc

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Orexigen Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

Capricor Therapeutics Inc

Capricor Therapeutics Inc

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Capricor Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

Antisense Therapeutics Limited

Antisense Therapeutics Limited

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Antisense Therapeutics Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

Celldex Therapeutics, Incorporation

Celldex Therapeutics, Incorporation

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Celldex Therapeutics, Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

Addex Therapeutics

Addex Therapeutics

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Addex Therapeutics compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

About 10 000 reports for Therapeutics

Download Unlimited Documents from Trusted Public Sources

Revance Therapeutics Incorporated Annual Report 2013

  • January 2013
    199 pages
  • Equity Market  

    Common Stock  

    Preferred Stock  

  • United States  

View report >

38 Companies for Therapeutics

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Pfizer Inc.

United States

Johnson and Johnson

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.